Achieve Life Sciences Inc

Company Profile

Achieve Life Sciences Inc had its IPO on 1995-10-13 under the ticker symbol ACHV.

The company operates in the Healthcare sector and Biotechnology industry. Achieve Life Sciences Inc has a staff strength of 16 employees.

Stock update

Shares of Achieve Life Sciences Inc opened at $4.54 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $4.27 - $4.7, and closed at $4.35.

This is a -2.03% slip from the previous day's closing price.

A total volume of 248,500 shares were traded at the close of the day’s session.

In the last one week, shares of Achieve Life Sciences Inc have slipped by -12.12%.

Achieve Life Sciences Inc's Key Ratios

Achieve Life Sciences Inc has a market cap of $90.38 million, indicating a price to book ratio of 44.2283 and a price to sales ratio of 0.

In the last 12-months Achieve Life Sciences Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-36820000. The EBITDA ratio measures Achieve Life Sciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Achieve Life Sciences Inc’s operating margin was 0% while its return on assets stood at -75.28% with a return of equity of -214.13%.

In Q3, Achieve Life Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Achieve Life Sciences Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-4.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Achieve Life Sciences Inc’s profitability.

Achieve Life Sciences Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.1913. Its price to sales ratio in the trailing 12-months stood at 0.

Achieve Life Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$23.72 million

Total Liabilities

$6.92 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Achieve Life Sciences Inc ended 2023 with $23.72 million in total assets and $0 in total liabilities. Its intangible assets were valued at $23.72 million while shareholder equity stood at $1.04 million.

Achieve Life Sciences Inc ended 2023 with $0 in deferred long-term liabilities, $6.92 million in other current liabilities, 79000.00 in common stock, $-124704000.00 in retained earnings and $1.03 million in goodwill. Its cash balance stood at $18.20 million and cash and short-term investments were $18.20 million. The company’s total short-term debt was $23,000 while long-term debt stood at $15.76 million.

Achieve Life Sciences Inc’s total current assets stands at $20.96 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $145000.00 compared to accounts payable of $412000.00 and inventory worth $0.

In 2023, Achieve Life Sciences Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Achieve Life Sciences Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$4.35

52-Week High

$8.13

52-Week Low

$2

Analyst Target Price

$24.75

Achieve Life Sciences Inc stock is currently trading at $4.35 per share. It touched a 52-week high of $8.13 and a 52-week low of $8.13. Analysts tracking the stock have a 12-month average target price of $24.75.

Its 50-day moving average was $4.74 and 200-day moving average was $4.17 The short ratio stood at 5.76 indicating a short percent outstanding of 0%.

Around 841.2% of the company’s stock are held by insiders while 3338.7% are held by institutions.